US Patent Litigations are now available. Check here

Explore Tcr Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP3298033Jul 12, 2023Compositions And Methods For Tcr Reprogramming Using Fusion Proteins1